Literature DB >> 15371790

Complications of clean intermittent catheterization in boys and young males with neurogenic bladder dysfunction.

B Lindehall1, K Abrahamsson, K Hjälmås, U Jodal, I Olsson, U Sillén.   

Abstract

PURPOSE: We evaluate the risk for urethral lesions and epididymitis in boys with neurogenic bladder dysfunction treated by clean intermittent catheterization (CIC) for a minimum of 10 years.
MATERIALS AND METHODS: The medical records of 28 males with neurogenic bladder dysfunction followed from the start of CIC until the age of 15 to 20 years were reviewed.
RESULTS: CIC had been performed for a median of 16 years (range 10 to 21). Overall CIC was used for 438 years (265 before and 173 after puberty). During 76% of the years a noncoated polyvinyl chloride catheter with lubrication was used and in 24% of years a hydrophilic coated polyvinyl chloride catheter was used. The catheter size was 12C or greater in 43% of the cases. Independence from self-catheterization occurred during 37% of the CIC years. Of the patients 19 experienced at least 1 episode of difficulty inserting the catheter and/or had macroscopic hematuria on a total of 42 occasions. Major urethral lesions were seen on cystoscopy in 7 patients on 9 occasions (5 false passages, 1 superficial recess, 2 meatal stenoses, 1 urethral stricture). Major urethral lesions were not associated with puberty and did not occur during self-catheterization or with use of catheters 12C or greater. Epididymitis was seen in only a 12 year-old boy.
CONCLUSIONS: The overall rate of complications was low. The incidence of major urethral lesions did not increase during puberty. Self-catheterization and 12C catheter or greater seemed to be protective against major lesions.

Entities:  

Mesh:

Year:  2004        PMID: 15371790     DOI: 10.1097/01.ju.0000138847.14680.7d

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Canadian Urological Association Best Practice Report: Catheter use.

Authors:  Lysanne Campeau; Samer Shamout; Richard J Baverstock; Kevin V Carlson; Dean S Elterman; Duane R Hickling; Stephen S Steele; Blayne Welk
Journal:  Can Urol Assoc J       Date:  2020-07       Impact factor: 1.862

Review 2.  [Neurogenic bladder function disorders in patients with meningomyelocele: S2k guidelines on diagnostics and therapy].

Authors:  R Stein; C Assion; R Beetz; M Bürst; R Cremer; A Ermert; M Goepel; E Kuwertz-Bröking; B Ludwikowski; T Michael; J Pannek; H Peters; D Rohrmann; I Rübben; A Schröder; R Trollmann; J W Thüroff; W Wagner
Journal:  Urologe A       Date:  2015-02       Impact factor: 0.639

Review 3.  [Urological problems in patients with meningomyelocele. Diagnostic studies and management].

Authors:  R Stein; A Schröder; R Beetz; A Ermert; D Filipas; M Fisch; M Goepel; I Körner; B Schönberger; C Sparwasser; M Stöhrer; J W Thüroff
Journal:  Urologe A       Date:  2007-12       Impact factor: 0.639

4.  Shifting to 4 × 1 intermittent catheterization without an early follow-up urodynamic study is possible in most patients with subacute spinal cord injury.

Authors:  Murat Ersöz; Engin Koyuncu; Müfit Akyüz; Neşe Özgirgin
Journal:  J Spinal Cord Med       Date:  2016-04-01       Impact factor: 1.985

5.  Ultrasonography and clinical findings in children with epididymitis, with and without associated lower urinary tract abnormalities.

Authors:  Boaz Karmazyn; Martin Kaefer; Shannon Kauffman; S Gregory Jennings
Journal:  Pediatr Radiol       Date:  2009-06-23

Review 6.  Effects of hydrophilic coated catheters on urethral trauma, microtrauma and adverse events with intermittent catheterization in patients with bladder dysfunction: a systematic review and meta-analysis.

Authors:  Xi Liao; Yuwei Liu; Shiqi Liang; Ka Li
Journal:  Int Urol Nephrol       Date:  2022-04-21       Impact factor: 2.266

Review 7.  A scoping review on the impact of hydrophilic versus non-hydrophilic intermittent catheters on UTI, QoL, satisfaction, preference, and other outcomes in neurogenic and non-neurogenic patients suffering from urinary retention.

Authors:  Kim Bundvig Barken; Rikke Vaabengaard
Journal:  BMC Urol       Date:  2022-09-19       Impact factor: 2.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.